Bernal-Casas, D.; Serrano-MarÃn, J.; Sánchez-Navés, J.; Oller, J.M.; Franco, R.
Advancing Personalized Medicine by Analytical Means: Selection of Three Metabolites That Allows Discrimination between Glaucoma, Diabetes, and Controls. Metabolites 2024, 14, 149.
https://doi.org/10.3390/metabo14030149
AMA Style
Bernal-Casas D, Serrano-MarÃn J, Sánchez-Navés J, Oller JM, Franco R.
Advancing Personalized Medicine by Analytical Means: Selection of Three Metabolites That Allows Discrimination between Glaucoma, Diabetes, and Controls. Metabolites. 2024; 14(3):149.
https://doi.org/10.3390/metabo14030149
Chicago/Turabian Style
Bernal-Casas, David, Joan Serrano-MarÃn, Juan Sánchez-Navés, Josep M. Oller, and Rafael Franco.
2024. "Advancing Personalized Medicine by Analytical Means: Selection of Three Metabolites That Allows Discrimination between Glaucoma, Diabetes, and Controls" Metabolites 14, no. 3: 149.
https://doi.org/10.3390/metabo14030149
APA Style
Bernal-Casas, D., Serrano-MarÃn, J., Sánchez-Navés, J., Oller, J. M., & Franco, R.
(2024). Advancing Personalized Medicine by Analytical Means: Selection of Three Metabolites That Allows Discrimination between Glaucoma, Diabetes, and Controls. Metabolites, 14(3), 149.
https://doi.org/10.3390/metabo14030149